This approach for FOXP3 gene transfer with adoptive cell therapy may potentially be a promising approach to treat IPEX patients as well as other autoimmune patients with dysfunctional human Tregs. The gene discussed is FOXP3; the disease is immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome.